Experience, education & publications

  1. Aug 2023 – Present Vancouver, BC, Canada Hybrid

    Graduate Research Assistant

    AI in Medicine LabPermanent full-time

    • Developed end-to-end PyTorch multiple-instance learning pipelines for pathology slide images with focuses on cohort shift, label stability, and task calibration
    • MSI screening strategy with 94% sensitivity and 98% NPV in multi-institutional external validation
    • Containerization, GPU-cluster workflows, multi-terabyte scale training and downstream analysis
  2. Jan 2024 – Aug 2024 Vancouver, BC, Canada Hybrid

    Machine Learning Research Intern

    Providence Health Care (St. Paul's Hospital)Co-op

    • Proposed an AI screening framework for pacemaker lead extractions using clinical CT images
    • Coordinated work with cardiac surgeons and presented at the UBC SBME Symposium
  3. Nov 2017 – Oct 2018 Toronto, ON, Canada On-site

    Software Developer

    StafitsPermanent full-time

    • Developed full-stack web and mobile applications using MongoDB, Express, React and Node.js; deployed backend services on AWS.
Additional Experience (2) MCAT instruction and pharmacy experience
  1. Jun 2022 – Dec 2023 San Diego, CA, USA Remote

    MCAT Instructor

    Kyo StandardContract part-time

    • Lesson planning and teaching complex concepts in an easy-to-understand way
  2. Apr 2023 – Jul 2023 Burnaby, BC, Canada On-site

    Pharmacy Assistant

    CareRx CorporationPermanent full-time

    • Compounding, aliquoting, and packaging various medications
  • Oct 2026

    Master of Applied Science, Biomedical Engineering

    University of British Columbia

    • Multi-Scale Multi-Modal Image and Omics Computing for Health Scholarship ($18,000)
    • CANTRAIN Clinical Trials Training Program Studentship ($17,500)
  • May 2022

    Bachelor of Science (Hons), Biology

    York University

  1. Hadjifaradji A, Diaz-Stewart M, Chu J, et al. A Deep Learning Framework for Classification of Neuroendocrine Neoplasm Whole Slide Images. Cancers. 2025;17(18):2991.

    doi:10.3390/cancers17182991
  2. Paul A, Mendis S, Diaz-Stewart M, et al. Comparison of Lanreotide and Octreotide LAR Use and Outcomes for Gastrointestinal Neuroendocrine Tumors in British Columbia, Canada. Cancer Control. 2026.

    doi:10.1177/10732748261417423